Affimed NV (AFMD)
4.97
+0.09
(+1.84%)
USD |
NASDAQ |
Apr 26, 14:49
Affimed Cash from Investing (TTM): -39.04M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -39.04M |
September 30, 2023 | -38.39M |
June 30, 2023 | 4.489M |
March 31, 2023 | 6.021M |
December 31, 2022 | 5.911M |
September 30, 2022 | 0.7557M |
June 30, 2022 | -1.329M |
March 31, 2022 | -3.510M |
December 31, 2021 | -4.555M |
September 30, 2021 | 6.604M |
June 30, 2021 | 6.434M |
March 31, 2021 | 3.880M |
December 31, 2020 | 9.143M |
September 30, 2020 | 8.407M |
June 30, 2020 | 17.45M |
March 31, 2020 | 29.04M |
December 31, 2019 | 4.859M |
September 30, 2019 | -20.70M |
June 30, 2019 | -29.74M |
March 31, 2019 | -38.32M |
December 31, 2018 | -18.43M |
Date | Value |
---|---|
September 30, 2018 | 8.830M |
June 30, 2018 | 4.110M |
March 31, 2018 | 4.174M |
December 31, 2017 | 9.117M |
September 30, 2017 | 4.975M |
June 30, 2017 | 15.17M |
March 31, 2017 | 14.76M |
December 31, 2016 | -10.13M |
September 30, 2016 | -15.44M |
June 30, 2016 | -20.88M |
March 31, 2016 | -20.40M |
December 31, 2015 | -0.3074M |
September 30, 2015 | -0.2763M |
June 30, 2015 | -0.4359M |
March 31, 2015 | -0.4024M |
December 31, 2014 | -0.3963M |
September 30, 2014 | -0.3728M |
June 30, 2014 | -0.0989M |
March 31, 2014 | -0.1385M |
December 31, 2013 | -0.2085M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-39.04M
Minimum
Dec 2023
29.04M
Maximum
Mar 2020
-1.804M
Average
4.489M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
InflaRx NV | -19.16M |
MorphoSys AG | -- |
BioNTech SE | -7.529B |
Immatics NV | -33.98M |
CureVac NV | -69.92M |